Inventor · Encinitas, CA, US

Benjamin Pratt

14Patents

2h-index

34Co-inventors

50Inventor score

Filing activity: Nov 9, 2006 → Jun 15, 2022

Most-cited inventions

Patent	Title	Area	Cited by	Status
US10167294B2	Fused bicyclic compounds for the treatment of disease	Human Necessities	11	Active
US10793577B2	Fused bicyclic compounds for the treatment of disease	Human Necessities	10	Active
US9150572B2	Substituted naphthyridine and quinoline compounds as MAO inhibitors	Chemistry; Metallurgy	2	Active
US8785488B2	Triazole and imidazole derivatives for use as TGR5 agonists in the treatment of diabetes and obesity	Chemistry; Metallurgy	2	Active
US9102674B2	Substituted naphthyridine and quinoline compounds as MAO inhibitors	Chemistry; Metallurgy	2	Active
US11365191B2	Substituted cyclohexyl compounds as NOP inhibiiors	Chemistry; Metallurgy	1	Active
US9675605B2	Substituted naphthyridine and quinoline compounds as MAO inhibitors	Chemistry; Metallurgy	1	Active
US8003801B2	Chemical synthesis of a highly potent epothilone	Chemistry; Metallurgy	0	Active
US10233187B2	Fused bicyclic compounds for the treatment of disease	Human Necessities	0	Active
US12410204B2	Chiral synthesis of a tertiary alcohol	Chemistry; Metallurgy	0	Active
US9956213B2	Substituted naphthyridine and quinoline compounds as MAO inhibitors	Chemistry; Metallurgy	0	Active
US10421759B2	Fused bicyclic compounds for the treatment of disease	Chemistry; Metallurgy	0	Active
US8846739B2	TGR5 agonists	Chemistry; Metallurgy	0	Active
US11945808B2	Substituted cyclohexyl compounds as NOP inhibitors	Chemistry; Metallurgy	0	Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.